Value of FDG PET/Contrast-Enhanced CT in Initial Staging of Colorectal Cancer - Comparison with Contrast-Enhanced CT |
Kunawudhi, Anchisa
(National Cyclotron and PET Centre, Chulabhorn Hospital)
Sereeborwornthanasak, Karun (Radiology Department, Bhumibol Adulyadej Hospital) Promteangtrong, Chetsadaporn (National Cyclotron and PET Centre, Chulabhorn Hospital) Siripongpreeda, Bunchorn (Radiology Department, Bhumibol Adulyadej Hospital) Vanprom, Saiphet (National Cyclotron and PET Centre, Chulabhorn Hospital) Chotipanich, Chanisa (National Cyclotron and PET Centre, Chulabhorn Hospital) |
1 | Petersen RK, Hess S, Alavi A, et al (2014). Clinical impact of FDG-PET/CT on colorectal cancer staging and treatment strategy. Am J Nucl Med Mol Imaging, 4, 471-82. |
2 | Selzner M, Hany TF, Wildbrett P, et al (2004). Does the novel PET/CT imaging modality impact on the treatment of patients with metastatic colorectal cancer of the liver? Ann Surg, 240, 1027-34. DOI |
3 | Shin SS, Jeong YY, Min JJ, et al (2008). Preoperative staging of colorectal cancer: CT vs. integrated FDG PET/CT. Abdom Imaging, 33, 270-7. DOI |
4 | Siegel R, Ma J, Zou Z, et al (2014). Cancer statistics, 2014. CA Cancer J Clin, 64, 9-29. DOI |
5 | Chowdhury FU, Shah N, Scarsbrook AF, et al (2010). [18F]FDG PET/CT imaging of colorectal cancer: a pictorial review. Postgrad Med J, 86, 174-82. DOI |
6 | Cipe G, Ergul N, Hasbahceci M, et al (2013). Routine use of positron-emission tomography/computed tomography for staging of primary colorectal cancer: does it affect clinical management? World J Surg Oncol, 11, 49. DOI |
7 | Filippone A, Ambrosini R, Fuschi M, et al (2004). Preoperative T and N staging of colorectal cancer: accuracy of contrastenhanced multi-detector row CT colonography--initial experience. Radiol, 231, 83-90. DOI |
8 | Kantorova I, Lipska L, Belohlavek O, et al (2003). Routine (18)F-FDG PET preoperative staging of colorectal cancer: comparison with conventional staging and its impact on treatment decision making. J Nucl Med, 44, 1784-8. |
9 | Liao CY, Chen SW, Wu YC, et al (2014). Correlations between 18F-FDG PET/CT parameters and pathological findings in patients with rectal cancer. Clin Nucl Med, 39, 40-5. DOI |
10 | Llamas-Elvira JM, Rodriguez-Fernandez A, Gutierrez-Sainz J, et al (2007). Fluorine-18 fluorodeoxyglucose PET in the preoperative staging of colorectal cancer. Eur J Nucl Med Mol Imaging, 34, 859-67. DOI |
11 | Park IJ, Kim HC, Yu CS, et al (2006). Efficacy of PET/CT in the accurate evaluation of primary colorectal carcinoma. Eur J Surg Oncol, 32, 941-7. DOI |
12 | Moulton CA, Gu CS, Law CH, et al (2014). Effect of PET before liver resection on surgical management for colorectal adenocarcinoma metastases: a randomized clinical trial. JAMA, 311, 1863-9. DOI |
13 | Niekel MC, Bipat S, Stoker J (2010). Diagnostic imaging of colorectal liver metastases with CT, MR imaging, FDG PET, and/or FDG PET/CT: a meta-analysis of prospective studies including patients who have not previously undergone treatment. Radiol, 257, 674-84. DOI |